1. [Home](https://www.g2.com/)
2. ...
3. [Drug Discovery Software](https://www.g2.com/categories/drug-discovery)
4. [Platforma Discussions](https://www.g2.com/products/milaboratories-platforma/discuss)

[
 ![Platforma](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_616eec71063c0c3dc38c39b222f9ee05/milaboratories-platforma.png "Platforma")
](/products/milaboratories-platforma/reviews)

# Platforma Discussions

Platforma is the discovery decision platform for biologics. It helps discovery teams turn complex sequencing, experimental, structural, and AI-derived data into transparent, evidence-based decisions about which therapeutic candidates to advance. Every discovery campaign generates millions of biological signals, yet the most important decision (which candidates move forward) is often made by piecing together fragmented analyses across spreadsheets, scripts, and disconnected bioinformatics tools. Platforma brings every relevant biological signal into a single, reproducible decision framework, giving scientists the complete biological picture at the moment decisions are made. With intuitive, no-code workflows built for antibody discovery and translational research, scientists can explore evidence, compare candidates, and understand exactly why leads are prioritized. Platforma combines trusted bioinformatics, developability assessments, structural insights, AI-powered analyses, and customizable decision logic into one collaborative environment. Platforma supports end-to-end biologics discovery, including: In vitro antibody discovery: Analyze display-based screening campaigns, identify enriched antibody candidates, combine enrichment, developability, structural, and AI-derived insights, and prioritize the strongest therapeutic leads using a transparent, evidence-based ranking. In vivo antibody discovery: Integrate immune repertoire sequencing with functional, structural, and developability data to characterize immune responses, identify high-potential candidates, and make confident lead selection decisions using the full biological picture. Peptide discovery, translational immune research & multiomics: Integrate diverse biological datasets—including peptide screening, immune repertoire, single-cell, and multiomic data—into one transparent, evidence-based framework for generating insights, prioritizing candidates, and accelerating biological discovery. Rather than simply managing datasets, Platforma accelerates discovery decisions, helping scientists choose better therapeutic candidates faster while ensuring every decision is transparent, reproducible, and backed by evidence.

## Be the first to start the conversation

Get answers from real professionals in the G2 community.